Saturday, July 09, 2011 7:52:47 AM
Getting the word out in various publications such as this is savy . Hollywood is a great place to target imo. People complain here because of lack of news by the company but one should note they couldn't advertise the treatment until it was approved 6/22. This is not a one mile turkey trot people. More like a 25k run imo. The negatives are the lack of cash and general market awareness (the ceo is changing the market awareness issue). We may face more dilution and growing pains in the coming weeks/months but this is what happens at this level. I have held ANX for 2 years and it is finally coming to fruition sp wise after a rs and share dilution to raise cash. Yes, it was frustrating. If one wants instant gratification they should try Mcdonalds. Otherwise walk away for awhile but realize this: You own the next generation of derm therapy/treatment here and given some time/money they will silence all critics. This is a blockbuster. Btw, I really don't expect much in this qtr just ended since it was just approved 6/22. glta longs
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM